Savara
SVRA
#6249
Rank
โ‚น87.08 B
Marketcap
โ‚น394.73
Share price
-18.23%
Change (1 day)
-10.45%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚น12.83 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น11.02 Billion a decrease over its 2024 earnings that were of -โ‚น8.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น12.83 Billion16.46%
2025 -โ‚น11.02 Billion23.94%
2024 -โ‚น8.89 Billion75.29%
2023 -โ‚น5.07 Billion43.38%
2022 -โ‚น3.54 Billion-11.31%
2021 -โ‚น3.99 Billion-13.3%
2020 -โ‚น4.6 Billion-36.53%
2019 -โ‚น7.25 Billion13.76%
2018 -โ‚น6.37 Billion105.54%
2017 -โ‚น3.1 Billion34.11%
2016 -โ‚น2.31 Billion-37.43%
2015 -โ‚น3.7 Billion38.81%
2014 -โ‚น2.66 Billion33.62%
2013 -โ‚น2 Billion38.49%
2012 -โ‚น1.44 Billion24.59%
2011 -โ‚น1.16 Billion-36.5%
2010 -โ‚น1.82 Billion-3.14%
2009 -โ‚น1.88 Billion-23.28%
2008 -โ‚น2.45 Billion8.52%
2007 -โ‚น2.26 Billion-34.14%
2006 -โ‚น3.43 Billion184.43%
2005 -โ‚น1.21 Billion90.75%
2004 -โ‚น0.64 Billion190.35%
2003 -โ‚น0.22 Billion11.64%
2002 -โ‚น0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.75 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.69 Billion-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA